Maravai Lifesciences Holdings (MRVI) Operating Expenses (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Operating Expenses of $35.9 million for Q1 2026, down 36.96% year-over-year from $56.9 million in Q1 2025, and down 49.94% quarter-over-quarter from $71.6 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Operating Expenses (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Operating Expenses history runs 7 years deep, the most recent figure standing at $35.9 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 36.96% year-over-year to $35.9 million; the TTM figure through Mar 2026 stood at $267.9 million (down 32.13% YoY), while the FY2025 annual figure was $249.3 million, down 27.53% from the prior year.
- Operating Expenses for Q1 2026 stood at $35.9 million, down from $71.6 million in the prior quarter.
- The five-year high for Operating Expenses was $197.8 million in Q3 2024, with the low at -$67.5 million in Q4 2023.
- The 5-year median for Operating Expenses is $76.5 million (2023), against an average of $72.1 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 170.65% in 2023, then soared 184.64% in 2024.
- Maravai Lifesciences Holdings' Operating Expenses stood at $95.5 million in 2022, then sank by 170.65% to -$67.5 million in 2023, then jumped by 184.64% to $57.1 million in 2024, then grew by 25.48% to $71.6 million in 2025, then tumbled by 49.94% to $35.9 million in 2026.
- Business Quant data shows MRVI's Operating Expenses at $35.9 million in Q1 2026, $71.6 million in Q4 2025, and $46.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 35.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.74 Mn |
| Mar 31, 2026 | 35.86 Mn |
| Dec 31, 2025 | 71.64 Mn |
| Sep 30, 2025 | 46.69 Mn |
| Jun 30, 2025 | 113.68 Mn |
| Mar 31, 2025 | 56.89 Mn |
| Dec 31, 2024 | 57.09 Mn |
| Sep 30, 2024 | 197.85 Mn |
| Jun 30, 2024 | 82.86 Mn |
| Mar 31, 2024 | 83.04 Mn |
| Dec 31, 2023 | -67.45 Mn |
| Sep 30, 2023 | 82.28 Mn |
| Jun 30, 2023 | 80.53 Mn |
| Mar 31, 2023 | 76.49 Mn |
| Dec 31, 2022 | 95.47 Mn |
| Sep 30, 2022 | 74.36 Mn |
| Jun 30, 2022 | 62.03 Mn |
| Mar 31, 2022 | 76.93 Mn |
| Dec 31, 2021 | 73.90 Mn |
| Sep 30, 2021 | 49.43 Mn |